Articles dans des revues avec comité de lecture (364)

  1. 106. Demeestere, I., Brice, P., Peccatori, F. A., Kentos, A., Gaillard, I., Zachée, P., Casasnovas, O., Van Den Neste, E., Dechene, J., De Maertelaer, V., Bron, D., & Englert, Y. (2013). Gonadotropin-releasing hormone agonist for the prevention of chemotherapy-induced ovarian failure in patients with lymphoma: 1-year follow-up of a prospective randomized trial. Journal of clinical oncology, 31(7), 903-909. doi:10.1200/JCO.2012.42.8185
  2. 107. Bosly, A., Grigg, A., Holte, H., Gisselbrecht, C., Radford, J., Rossi, A., Lopez-Guillermo, A., Trneny, M., Sebban, C., Hagberg, H., da Costa, F. L., Colombat, P., Bron, D., & Coiffier, B. (2013). A randomized study of interferon α-2b versus no treatment as consolidation after high dose therapy and autologous stem cell transplantation for patients with relapsed lymphoma. The oncologist, 18(11), 1189. doi:10.1634/theoncologist.2013-0223
  3. 108. Roos-Weil, D., Dietrich, S., Dreger, P., Boumendil, A., Polge, E., Bron, D., Carreras, E., Atienza, A. I., Arcese, W., Beelen, D. W., Cornelissen, J. J., Kröger, N., Milone, G., Rossi, G., Jardin, F., Peters, C., Rocha, V., Sureda, A., & Mohty, M. (2013). Stem cell transplantation can provide durable disease control in blastic plasmacytoid dendritic cell neoplasm: A retrospective study from the European Group for Blood and Marrow Transplantation. Blood, 121(3), 440-446. doi:10.1182/blood-2012-08-448613
  4. 109. Verhoef, G., Schroyens, W., Bron, D., Bonnet, C., De Wilde, V., Van Hoof, A., Janssens, A., Dierickx, D., Andre, M., & Vandenneste, E. (2013). Guidelines newly diagnosed diffuse B-large cell lymphoma (DLBCL) and relapsed DLBCL. Belgian Journal of Hematology, 4(2), 51-57.
  5. 110. Najar, M., Raicevic, G., De Bruyn, C., Bron, D., Toungouz Nevessignsky, M., Lagneaux, L., & Fayyad Kazan, H. (2012). Erratum to: Immune-Related Antigens, Surface Molecules and Regulatory Factors in Human-Derived Mesenchymal Stromal Cells: The Expression and Impact of Inflammatory Priming(Stem Cell Rev and Rep, 10.1007/s12015-012-9408-1). Stem cell reviews, 8(4), 1286. doi:10.1007/s12015-012-9415-2
  6. 111. Van Damme, M., Crompot, E., Meuleman, N., Mineur, P., Bron, D., Lagneaux, L., & Stamatopoulos, B. (2012). HDAC isoenzyme expression is deregulated in chronic lymphocytic leukemia B-cells and has a complex prognostic significance. Epigenetics, 7(12), 1403-1412. doi:10.4161/epi.22674
  7. 112. Najar, M., Raicevic, G., Fayyad Kazan, H., Kazan, H. F., De Bruyn, C., Bron, D., Toungouz Nevessignsky, M., & Lagneaux, L. (2012). Immune-related antigens, surface molecules and regulatory factors in human-derived mesenchymal stromal cells: the expression and impact of inflammatory priming. Stem cell reviews, 8(4), 1188-1198. doi:10.1007/s12015-012-9408-1
  8. 113. Vaes, M., Hites, M., Cotton, F., Bourguignon, A., Csergo, M., Rasson, C., Ameye, L., Bron, D., Jacobs, F., & Aoun, M. (2012). Therapeutic drug monitoring of posaconazole in patients with acute myeloid leukemia or myelodysplastic syndrome. Antimicrobial agents and chemotherapy, 56(12), 6298-6303. doi:10.1128/AAC.01177-12
  9. 114. Muylle, K., Nguyen, J., de Wind, A., Meuleman, N., Delatte, P., Vanderlinden, B., Roelandts, M., Van der Stappen, A., Bron, D., & Flamen, P. (2012). Radioembolization of the Spleen: A Revisited Approach for the Treatment of Malignant Lymphomatous Splenomegaly. Cardiovascular and interventional radiology. doi:10.1007/s00270-012-0484-z
  10. 115. Najar, M., Raicevic, G., Jebbawi, F., De Bruyn, C., Meuleman, N., Bron, D., Toungouz Nevessignsky, M., & Lagneaux, L. (2012). Characterization and functionality of the CD200-CD200R system during mesenchymal stromal cell interactions with T-lymphocytes. Immunology letters, 146(1-2), 50-56. doi:10.1016/j.imlet.2012.04.017
  11. 116. Raicevic, G., Najar, M., Pieters, K., De Bruyn, C., Meuleman, N., Bron, D., Toungouz Nevessignsky, M., & Lagneaux, L. (2012). Inflammation and Toll-like receptor ligation differentially affect the osteogenic potential of human mesenchymal stromal cells depending on their tissue origin. Tissue Engineering. Part A. Tissue Engineering, 18(13-14), 1410-1418. doi:10.1089/ten.TEA.2011.0434
  12. 117. Cuccuini, W., Briere, J., Mounier, N., Voelker, H.-U., Rosenwald, A., Sundstrom, C., Cogliatti, S., Hirchaud, E., Ysebaert, L., Bron, D., Soulier, J., Gaulard, P., Houlgatte, R., Gisselbrecht, C., & Thieblemont, C. (2012). MYC+ diffuse large B-cell lymphoma is not salvaged by classical R-ICE or R-DHAP followed by BEAM plus autologous stem cell transplantation. Blood, 119(20), 4619-4624. doi:10.1182/blood-2012-01-406033

  13. << Précédent 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36
    37
    38 Suivant >>